We have reached final binding agreements with the U.S. Government; pursuant to the agreements, the applicable tariff rate under the April 2, 2026 Section 232 Executive Order for Pfizer products will be zero until January 20, 2029
We have not seen a significant disruption of our supply chain in the first six months of 2026 and all of our manufacturing sites globally have continued to operate at or near normal levels
We do not anticipate the availability of raw materials to have a significant impact on our operations in 2026
no findingread · nothing bore on it
It held on this filing. No finding was written because nothing in it bore on the reason — the sentences it was read against are below.
the evidence · every sentence checkedthree sentences · whole, uncut
the claims it rests on · in our words, not the filing’s